Thanh Dellinger

Gynecologic Oncologist
Associate Clinical Professor
@CityofHope
@CityofHopeSurg

[Joshua Garrett Cohen @JCohenMD]

Wonderful to have amazing ⁦⁦⁦@cityofhope⁩ colleagues/partners who gave inspiring talks this evening about the state of the science in #gynecologiconcology #summit ⁦@cityofhopeoc⁩ ⁦@DrSCohen⁩ ⁦@TDellingerMD⁩ #teamscience

[Joshua Garrett Cohen @JCohenMD]

Wonderful two days working with fellows from across the country. Cures for cancer require great surgery. I'm confident meeting these wonderful young surgeons that patients will be in great hands. #SGOFellowsCourse. @SGO_org @TDellingerMD @SGO_org

[Thanh Dellinger @TDellingerMD]

City of Hope PIPAC trials in gastric and biliary tract cancer featured at @PSOGI_EC PSOGI 2025 in Barcelona @MustafaRaoofMD #yanghee Woo @cityofhope @CityofHopeSurg by @WimCeelen nanoparticle IP trial talk

[Thanh Dellinger @TDellingerMD]

Excited be at ASCO to present our collaboration with CHU Lyon on potential predictive biomarkers for response to HIPEC @cityofhope @COH_GynOncology @CityofHopeSurg @ISSPP1 @PSOGI_EC @bakrinna

[Thanh Dellinger @TDellingerMD]

Excited to visit Albert Einstein for the PIPAC master course this week @ISSPP1 #US PIPAC Collaborative @RafaelSeitenfus @pipacbrasil @MAReymond @COH_GynOncology @CityofHopeSurg

[Lana Bijelic @LanaBijelicMD]

It's a pleasure to share our newly published Video-article on Classic and Visceral-sparing Pelvic peritonectomy for Peritoneal Surface Malignancies in Annals of Surgical Oncology-hope you enjoy it!

https://t.co/lMIyOa77rv

@AnnSurgOncol @PSOGI_EC @indepso @ESSOnews @SocSurgOnc

[Thanh Dellinger @TDellingerMD]

Gyn onc surgeons cooking Mediterranean cuisine - surgeons translating OR skills into delicious meals @COH_GynOncology @CityofHopeSurg @cityofhopeoc @ErnestHanMD

[M. Talha Waheed @mtalhawaheed]

PIPAC-Ox vs. 3rd-line standard therapy for CRC & AC carcinomatosis in @AnnSurgOncol

Promising future for PIPAC

⬆️ Good days- days alive & outside 🏥
⬆️ OS- 11.3 vs. 5.1 mo
⬆️ PFS- 2.9 vs. 2.1 mo: NS

Next step ❓Randomized Trial !

@MustafaRaoofMD @TDellingerMD @COH_SurgOnc

[Thanh Dellinger @TDellingerMD]

PIPAC mitomycin C study is feasible and shows promising response, by @MustafaRaoofMD on behalf of U.S. PIPAC Consortium at @PSOGI_EC @ISSPP1 meeting in Lyon @merchea_md #larrywhelan @DKDePeralta @CityofHopeSurg @COH_GynOncology

[Thanh Dellinger @TDellingerMD]

Walk for hope at @CityofHopeSurg @COH_GynOncology @ErnestHanMD

[Amit Merchea @merchea_md]

Amazing progress for #PIPAC in 🇺🇸. From treating the 1st patient @MayoClinic, to launching the 1st clinical trial led by @MustafaRaoofMD @TDellingerMD @cityofhope & with @DKDePeralta @NorthwellHealth. Now training the next group of 🇺🇸 surgeons at 2nd US PIPAC Workshop. #teamwork

[Thanh Dellinger @TDellingerMD]

Happy to announce our second PIPAC training course taking place in July 28 and 29, 2024 at City of Hope, CA. https://t.co/zD7d1fpqlX
@MustafaRaoofMD @ISSPP1 @merchea_md @COH_GynOncology @CityofHopeSurg

[Thanh Dellinger @TDellingerMD]

Brilliant study to de-escalate platinum sensitive recurrent ovarian cancer therapy after 2’ CRS w/ olaparib pre +postop vs adjuv. chemo alone (Lheureux, ASCO). Would love to see a study adding HIPEC here given synergy with PARPi @StephanieLheur5 @ClasseJean @wvdriel

[Annals of Surgical Oncology @AnnSurgOncol]

#AudioVisualAbstract : Impact of #SodiumThiosulfate on Prevention of Nephrotoxicities in #HIPEC : An Ancillary Evaluation of Cisplatin-Induced Toxicities in #OvarianCancer @RSenMD @TDellingerMD

https://t.co/6pOAkcP9bF

@SyedAAhmad5
@esragbilir

[Mustafa Raoof @MustafaRaoofMD]

Investigating PIPAC in the US has been a huge team effort @merchea_md #larrywhelan @TDellingerMD @mgfakih @Yanghee61217641 @DKDePeralta.

Thanks @SocSurgOnc @RupenShahMD @SamRuff_MD for inviting us!

Bottom line: we need well designed randomized trials to move the needle in PSM

[Indian society of peritoneal surface malignancy @IspsmHipec]

@IspsmHipec
@somusp9
@ECPSOGI
@TDellingerMD
@ISSPP1
@oliviawriting
@DeliaCortesGuir
@DrSGlezMoreno
@RobellaManuela

[Peritoneal Surface Oncology Group International @PSOGI_EC]

📅Save the Date!
📢 The first PSOGI-ISSPP joint congress on peritoneal surface malignancies
⌛ 26-28 september 2024 / Lyon, France

🤝 The principal key word of this event will be “Multidisciplinary” around the peritoneum.

Follow '14th international congress PSOGI/ISSPP' on linked-in for regular updates
https://t.co/gWWlHZwsId

❗ More information on the official website: https://t.co/Xe2K07YoQE
➕ Join our mailing list to receive all the news from the congress: https://t.co/YwT9VpCE6H

This is the first congress that will join forces from the Peritoneal Surface Oncology Group International (PSOGI) and the ISSPP e.V. | International Society for the Study of Pleura and Peritoneum, the two major International Organizations dedicated to the management of Peritoneal Surface Malignancies (PSM).

@RENAPE_Network @glehenolivier @PSugarbaker @bakrinna @VahanKepenekian @FredericBibeau #MARCPOCARD

@speritoneum @ISSPP1 @APeritoneum @indepso @Israelisso @Some4SurgeryIT1 @IJGConline @alarjosan @AndreasBrandl8 @Elizabeth_Tremb @ANikiforchin @kturaga @AmanielKefley @KurtSpeeten @ESSOnews @ejsotweets @SocSurgOnc @AnnSurgOncol @NirajGusani @CarlosHFChan @Dr_Jamie_Murphy @FaekJ @MustafaRaoofMD @TDellingerMD @dr_mohammadyami @mssalshahrani @docswapnil01 @NewsJellybelly @PMPSurvivor

[Lana Bijelic @LanaBijelicMD]

Still time to register for the @ESSOnews webinar on surgical technique of CRS-Part 1! Tomorrow 28 Nov we will review surgical videos and reveal all the tips&tricks of pelvic peritonectomy. Happy to share the discussion with @DrSGlezMoreno @VadimGushchin6 @TDellingerMD

[Peritoneal Surface Oncology Group International @PSOGI_EC]

Unique opportunity to learn from the very best!
Technical aspects of pelvic peritonectomy..
Do not miss this free @ESSOnews webinar with
@LanaBijelicMD @DrSGlezMoreno @VadimGushchin6 @TDellingerMD
@IJGConline @IJGCfellows @agz_eriksson @Bhandoria @JayrajAarthi @OncoAlert @EYSAC1

[Julián Henao Ardila @JulianHenao85]

This is an invitation to the webinar about; CRS for PSM: pelvic peritonectomy with and without visceral resection. Speaker: @LanaBijelicMD, Moderators: @TDellingerMD, @DrSGlezMoreno, and @VadimGushchin6 . Date: 28 November 2023 https://t.co/DraehtzCTs